- P-ISSN 1010-0695
- E-ISSN 2288-3339
- Apply for Authority
- P-ISSN1010-0695
- E-ISSN2288-3339
Article Detail
Home > Article Detail
Review of Silymarin as a Model for Hepatotherapeutic Drug Development Using Herbal Resources
Journal of Korean Medicine / Journal of Korean Medicine, (P)1010-0695; (E)2288-3339
2008, v.29 no.3, pp.124-130
&
(2008). Review of Silymarin as a Model for Hepatotherapeutic Drug Development Using Herbal Resources. Journal of Korean Medicine, 29(3), 124-130.
- Downloaded
- Viewed
Abstract
Herbal plants or traditional Oriental medicine have been considered as a potential resource of new drug development worldwide. However, traditional Korean medicine has given little effort to the field of new drug development. This study reports on a plant-derived hepatotherapeutic drug, silymarin, which has been popularly used in many countries. It was discovered as an active compound from Silybum marianum (milk thistle) which has been known as a medicinal plant having hepatoprotective properties in both European and Asian countries. While it has been used as an herbal prescription in Asia, its active compounds or scientific mechanisms were intensively studied in Europe. Currently, silymarin is one of the most powerful herbal extracts in the world, and its usage is being expanded to many other medical purposes. This report would be helpful for providing an informative example of herbal-derived drug development to Oriental doctors or scientists in the Oriental medicinal field.
- keywords
- Oriental medicine, traditional Korean medicine, silymarin, Silybum marianum, milk thistle, hepatoprotective
Reference
1
1. de Franchis R, Hadengue A, Lau G, Lavanchy D, Lok A, McIntyre N, Mele A, Paumgartner G, Pietrangelo A, Rodes J, Rosenberg W, Valla D. EASL International Consensus Conference on Hepatitis B. J Hepatol. 2003;39 (1):S3-S25
2
2. Han KH, Kim JK. Liver cancer in Korea. Hepatol Res. 2007;37(2):S106-109.
3
3. Shao ZJ, Xu DZ, Xu JQ, Li JH, Yan YP, Men K, Wang XP, Zhang ZY, Jiang QW, Zhang L. Maternal hepatitis B virus (HBV) DNA positivity and sexual intercourse are associated with HBV intrauterine transmission in China: a prospective case-control study. J Gastroenterol Hepatol. 2007;22(2):165-170.
4
4. Shin JW, Son JY, Oh SM, Han SH, Wang JH, Cho JH, Cho CK, Yoo HS, Lee YW, Lee MM, Hu XP, Son CG. An herbal formula, CGX, exerts hepatotherapeutic effects on dimethylni- trosamine-induced chronic liver injury model in rats. World J Gastroenterol. 2006 ;12(38): 6142-6148
5
5. Leemans WF, Janssen HL, de Man RA. Future prospectives for the management of chronic hepatitis B. World J Gastroenterol. 2007 14; 13(18):2554-267.
6
6. Graf TN, Wani MC, Agarwal R, Kroll DJ, Oberlies NH. Gram-Scale Purification of Flavonolignan Diastereoisomers from Silybum marianum (Milk Thistle) Extract in Support of Preclinical in vivo Studies for Prostate Cancer Chemoprevention. Planta Med. 2007;73(14): 1495-1501.
7
7. Vaknin Y, Hadas R, Schafferman D, Murkh- ovsky L, Bashan N. The potential of milk thistle (Silybum marianum L.), an Israeli native, as a source of edible sprouts rich in antioxidants. Int J Food Sci Nutr. 2007;20:1-8.
8
8. 강병수, 김영배. 임상배합본초학. 영림사 1994; 779.
9
9. Gebhardt R. Antioxidative, antiproliferative and biochemical effects in HepG2 cells of a homeopathic remedy and its constituent plant tinctures tested separately or in combination. Arzneimittelforschung. 2003;53(12):823-30.
10
10. Laekeman G, De Coster S, De Meyer K. St. Mary's Thistle: an overview: K.U.Leuven.J Pharm Belg. 2003;58(1):28-31.
11
11. Park JW. Hepatocellular carcinoma in Korea introduction and overview. Korean J Gastroe- ntrol, 2005;45(4):217-226
12
12. Lee GJ, Cho JH, Cho CK, Son CG. Case study of HBV-related disasters in a high-risk family, Korean J of Oriental medicine, 2005;26:168 -173
13
13. Gazák R, Walterová D, Kren V. Silybin and silymarin-new and emerging applications in medicine: Curr Med Chem. 2007;14(3):315-338.
14
14. Pradhan SC, Girish C. Hepatoprotective herbal drug, silymarin from experimental pharmac- ology to clinical medicine: Indian J Med Res. 20061;24(5):491-504.
15
15. Schopen RD, Lange OK. Therapy of Hepat- oses. Therapeutic Use of Silymarin. Med Welt 1970;21:691-698.
16
16. Ramakrishnan G, Augustine TA, Jagan S, Vinodhkumar R, Devaki T. Effect of silymarin on N-nitrosodiethylamine induced hepatocarc- inogenesis in rats. Exp Oncol. 2007 ;29(1): 39-44.
17
17. Saller R, Melzer J, Reichling J, Brignoli R, Meier R.An updated systematic review of the pharmacology of silymarin. Forsch Komple- ment Med. 2007;14(2):70-80.
18
18. Kiruthiga PV, Shafreen RB, Pandian SK, Devi KP. Silymarin protection against major reactive oxygen species released by environmental toxins: exogenous H2O2 exposure in erythrocytes. Basic Clin Pharmacol Toxicol. 2007;100(6): 414-419.
19
19. Polyak SJ, Morishima C, Shuhart MC, Wang CC, Liu Y, Lee DY. Inhibition of T-cell infla- mmatory cytokines, hepatocyte NF-kappaB signaling, and HCV infection by standardized Silymarin. Gastroenterology. 2007;132(5):1925 -1936.
20
20. Huseini HF, Larijani B, Heshmat R, Fakhr- zadeh H, Radjabipour B, Toliat T, Raza M.The efficacy of Silybum marianum (L.) Gaertn. (silymarin) in the treatment of type II diabetes: a randomized, double-blind, placebo-controlled, clinical trial. Phytother Res. 2006 ;20(12): 1036-1039. (544)
21
21. Kang JS, Park SK, Yang KH, Kim HM. Silymarin inhibits TNF-alpha-induced expres- sion of adhesion molecules in human umbilical vein endothelial cells. FEBS Lett. 2003;550 (1-3):89-93.
22
30. American Liver Foundation, Available from URL: http://www.liverfoundation.org
23
31. CTTO, Available from URL: http://www.cttq.com.cn
24
32. Levy C, Seeff LD, Lindor KD. Use of herbal supplements for chronic liver disease. Clin Gastroenterol Hepatol. 2004;2(11):947-956.
- Downloaded
- Viewed
- 0KCI Citations
- 0WOS Citations
Other articles from this issue
- Bacterial Reverse Mutation Test of Sipjeondaebo-tang
- Study on Moxa density-related Changes in Warm Needle Temperature
- Immunostimulating Effect of Palmiboshinwhan (baweibushenwan) Extracts in Methotrexate-induced Immunosuppressed SD rats.
- Correlations of Subclinical Hypothyroidism with Serum Lipid Profiles and Obesity Index
- Effects of Samiunkyungtang on inflammation and fecal enzymes in ulcerative colitis animal model
- Effects of Gamijinhae-tang (Jiaweizhenke-tang) on Tracheal Smooth Muscle Contraction and Mucin Secretion from Airway Epithelial Cells
- Effects of Haengso-tang and Chwiyeon-tang on Expression of Respiratory Mucin Gene and Secretion of Airway Mucus
- In Vitro Study of Anti-inflammatory and Analgesic Effects of Salvia Miltiorrhiza (SM) Extracts Using Luciferase Reporter Gene Assay
- Status of changes in the business environment of Oriental medicine clinics- With the focus on their facilities, staff, patients and service fee revenue -
- A Study on the Percentage of Body Fat and Abdominal Obesity of Workers Using Bioelectrical Impedance Analysis
- Review of Silymarin as a Model for Hepatotherapeutic Drug Development Using Herbal Resources
- A Clinical Study to Observe Nasolabial Angle on Facial Palsy Sequelae by Disproportional Muscles of Expression
- Effects of Lycii Fructus on the Ovariectomized Osteoporosis of Rats
- A Case of Tolosa-Hunt Syndrome Treated with Herbal Medicine and Electroacupuncture at Oculomotor Muscles
- A Case report of Verruca Plana
- more
Recommanded Articles
This website recommended the use the Chrome browser for journal website.